News

February 12, 2019February 12, 2019

Treatment Shows Favorable Outcomes for Patients with Juvenile Myasthenia Gravis, Study Reports

News

Treatment of juvenile myasthenia gravis (JMG) lessens the severity of symptoms in most patients, leading to stable remission without significant amounts of medication, according to a study of Polish ... Read more

February 7, 2019February 7, 2019

MicroRNA-653 a Potential Therapeutic Target in Myasthenia Gravis, Mouse Study Shows

News

A small regulatory RNA, called microRNA-653, inhibited the proliferation of thymus cells, called thymocytes, in a mouse model of myasthenia gravis (MG), a study reports. Given that the thymus ... Read more

February 5, 2019February 5, 2019

Hearing Tests Can Help Diagnose, Monitor MG, Study Suggests

News

The inner ear function in myasthenia gravis (MG) patients is significantly impaired, and hearing tests can serve as a diagnostic and monitoring tool, scientists from South Korea say. Their ... Read more

January 31, 2019January 31, 2019

Repetitive Nerve Stimulation Test Can Be Useful Diagnostic Tool in MG Crisis, Study Finds

News

A repetitive nerve stimulation test can be a fast and accurate diagnostic tool for myasthenia gravis patients undergoing a myasthenic crisis. The study, “Repetitive Nerve Stimulation Test in Myasthenic Crisis,” was published in ... Read more

January 29, 2019January 29, 2019

Thymectomy Offers Good Long-term Effects for MG Patients, Study Finds

News

Thymectomy — removal of the thymus gland — provides clinical benefits to non-thymomatous myasthenia gravis patients for as long as five years after the procedure, according to a follow-up study. The ... Read more

January 24, 2019January 24, 2019

Flu Vaccine Safe and Effective for AChR Antibody-positive MG Patients, Study Reports

News

Patients with myasthenia gravis (MG), who are positive for the acetylcholine receptor (AChR) antibody, respond effectively to influenza vaccination, even if taking immunosuppressants. Also, influenza vaccination is safe, and ... Read more

January 22, 2019January 22, 2019

Obstructive Sleep Apnea More Likely in Males and Obese Myasthenia Gravis Patients, Study Reports

News

Among myasthenia gravis patients (MG), males and those with a higher body mass index are at a higher risk of obstructive sleep apnea, which is similar to what has ... Read more

January 17, 2019January 17, 2019

IL-23/Th17 Cell Pathway May Be New Target to Control Inflammation in MG Patients, Study Shows

News

A team of French researchers may have found a new therapeutic target, the IL-23/Th17 signaling cascade, to control tissue inflammation in patients with myasthenia gravis. The study, “Il-23/Th17 cell ... Read more

January 15, 2019January 15, 2019

MG-ADL Symptom Scale Would Benefit from Questions on Generalized Weakness, Study Says

News

MG-ADL, a patient-reported scale commonly used to address symptom severity in myasthenia gravis (MG), has a poor sensitivity for measuring generalized muscle weakness. Researchers suggest that more questions about ... Read more

January 10, 2019January 10, 2019

Phase 2b Trial Finds Firdapse Effective, Safe in Adults with MuSK-MG

News

Treatment of adult MuSK-antibody positive myasthenia gravis (MuSK-MG) patients with the investigational therapy Firdapse (amifampridine phosphate) improved muscle strength, eased fatigue, and was safe, according to full results of a Phase 2b ... Read more

Pin It on Pinterest